This process has an unfavorable role in atherosclerosis: SGEF-/- mice demonstrate a significant reduction in the formation of atherosclerotic plaque and was suggested as a novel therapeutic target, also since there appeared to be no other negative phenotypes18, 19. The gene discussed is ARHGEF26; the disease is atherosclerosis.